SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-003583
Filing Date
2008-05-09
Accepted
2008-05-09 11:49:41
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 EPIX PHARMACEUTICALS, INC. FORM 10-Q b69706epe10vq.htm 10-Q 187856
2 EX-10.1 RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN EPIX PHARM b69706epexv10w1.htm EX-10.1 247965
3 EX-31.1 CERTIFICATION PURSUANT TO RULE 13(A)-14(A) OR RULE 15D-14(A) OF SECURITI b69706epexv31w1.htm EX-31.1 8149
4 EX-31.2 CERTIFICATION PURSUANT TO RULE 13(A)-14(A) OR RULE 15D-14(A) OF SECURITI b69706epexv31w2.htm EX-31.2 8134
5 EX-32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO b69706epexv32w1.htm EX-32.1 4173
  Complete submission text file 0000950135-08-003583.txt   457716
Mailing Address 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address 4 MAGUIRE ROAD LEXINGTON MA 02421 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

IRS No.: 043030815 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21863 | Film No.: 08816847
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1